We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
(+58%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
22.72%
Top 10 Holdings %
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.9M |
| 2 |
Pfizer
PFE
|
+$37.8M |
| 3 |
Honeywell
HON
|
+$33.2M |
| 4 |
JPMorgan Chase
JPM
|
+$32.4M |
| 5 |
CME Group
CME
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$33.3M |
| 2 |
PayPal
PYPL
|
+$33.1M |
| 3 |
Amazon
AMZN
|
+$32.1M |
| 4 |
PPG Industries
PPG
|
+$27.6M |
| 5 |
Autodesk
ADSK
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 14.63% |
| 3 | Healthcare | 13.67% |
| 4 | Financials | 11.93% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Avista
AVA
$3.47B
| $823K | 0.01% |
+22,619
| New | +$896K |
|
1052
Monro
MNRO
$525M
| $821K | 0.01% |
+14,941
| New | +$795K |
|
1053
Motorola Solutions
MSI
$69.4B
| $818K | 0.01% |
5,836
-19,163
| -77% | -$2.71M |
|
|
MIK
1054
DELISTED
Michaels Stores, Inc
MIK
| $816K | 0.01% |
115,372
-951,690
| -89% | -$3.73M |
|
1055
AB InBev
BUD
$158B
| $815K | 0.01% |
16,531
+10,074
| +156% | +$471K |
|
1056
First Horizon
FHN
$12.1B
| $810K | 0.01% |
81,334
-73,209
| -47% | -$665K |
|
1057
First Solar
FSLR
$21.8B
| $809K | 0.01% |
16,347
-93,912
| -85% | -$4.19M |
|
1058
Radian Group
RDN
$5.14B
| $807K | 0.01% |
+52,055
| New | +$770K |
|
1059
Teleflex
TFX
$5.85B
| $807K | 0.01% |
2,218
-4,281
| -66% | -$1.48M |
|
1060
Carpenter Technology
CRS
$30B
| $806K | 0.01% |
33,192
-49,254
| -60% | -$1.09M |
|
1061
AGCO
AGCO
$8.78B
| $805K | 0.01% |
14,507
-81,258
| -85% | -$4.24M |
|
|
FLXN
1062
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $804K | 0.01% |
61,155
+20,112
| +49% | +$209K |
|
1063
Eagle Materials
EXP
$6.6B
| $802K | 0.01% |
+11,416
| New | +$718K |
|
|
HMSY
1064
DELISTED
HMS Holdings Corp.
HMSY
| $802K | 0.01% |
24,764
+5,701
| +30% | +$165K |
|
|
PRVL
1065
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $802K | 0.01% |
53,859
+36,677
| +213% | +$565K |
|
1066
iShares Russell 1000 ETF
IWB
$47.7B
| $800K | 0.01% |
+4,662
| New | +$754K |
|
1067
Stepan Co
SCL
$1.31B
| $798K | 0.01% |
8,218
-5,708
| -41% | -$537K |
|
1068
ArcBest
ARCB
$3.44B
| $795K | 0.01% |
30,000
+4,325
| +17% | +$92.7K |
|
1069
iShares MSCI Singapore ETF
EWS
$1.01B
| $795K | 0.01% |
+42,344
| New | +$781K |
|
|
VRNT
1070
DELISTED
Verint Systems
VRNT
| $786K | 0.01% |
+34,137
| New | +$756K |
|
1071
Ingredion
INGR
$6.38B
| $785K | 0.01% |
9,458
-9,145
| -49% | -$748K |
|
1072
MGE Energy Inc
MGEE
$3.11B
| $785K | 0.01% |
+12,167
| New | +$794K |
|
|
HRC
1073
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $785K | 0.01% |
7,150
+3,915
| +121% | +$410K |
|
|
SPTN
1074
DELISTED
SpartanNash
SPTN
| $784K | 0.01% |
36,900
-3,159
| -8% | -$56.7K |
|
1075
Karyopharm Therapeutics
KPTI
$168M
| $783K | 0.01% |
2,757
-1,059
| -28% | -$313K |
|
Similar funds
Squarepoint's Q2 2020 Portfolio in Review
As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.
- Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
- Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
- Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
- Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
- Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
- Squarepoint opened 906 new positions and closed 520 in Q2 2020.
- Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.
Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.